BEIJING, April 14 /PRNewswire-Asia-FirstCall/ -- China Medical
Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based
advanced in-vitro diagnostic ("IVD") company, today announced that it will
attend the 63rd China International Medical Equipment Fair ("CMEF") from April
18 to April 21, 2010 in Shenzhen, China.
China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology as well as Enhanced Chemiluminescence Immunoassay (ECLIA) technology, an immunodiagnostic technology to develop, manufacture and distribute diagnostic products for the detection of various cancers, diseases and disorders. The Company generates all revenues in China by selling diagnostic consumables including FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitals which are recurring users of the consumables for their patients. The Company sells FISH probes and SPR chips to large hospitals through its direct sales force and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit http://www.chinameditech.com .
Advertisement
Exhibition details
Event: 63rd China International Medical Equipment Fair
Date: April 18 - 21, 2010
Venue: Shenzhen Convention and Exhibition Center, Shenzhen, China
Booth Number: D06, Exhibition Hall 2 (CMEF IVD Area)
The Company will introduce the following products:
Molecular diagnostic segment
-- SPR W2600 Automatic Analyzer
-- SPR-based HPV DNA chip
-- Over 10 applications of FISH probes
Immunodiagnostic segment
-- AUTOMAGLIA 90 Automatic Chemiluminescence Analyzer
-- MAGLIA 60 Automatic Chemiluminescence Analyzer
-- JETLIA 96/2 Semi-automatic Chemiluminescence Analyzer
-- BIOZYME V Magnetic Separation Immunoassay Analyzer
-- Over 70 types of reagent kits
About China Medical Technologies, Inc.Advertisement
China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology as well as Enhanced Chemiluminescence Immunoassay (ECLIA) technology, an immunodiagnostic technology to develop, manufacture and distribute diagnostic products for the detection of various cancers, diseases and disorders. The Company generates all revenues in China by selling diagnostic consumables including FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitals which are recurring users of the consumables for their patients. The Company sells FISH probes and SPR chips to large hospitals through its direct sales force and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit http://www.chinameditech.com .
For more information, please contact:
Winnie Yam
Tel: +852-2511-9808
Email: [email protected]
SOURCE China Medical Technologies, Inc.